For research use only. We do not sell to patients.
| Name | Sapacitabine |
|---|---|
| Iupac Chemical Name | N-(1-((2R,3S,4S,5R)-3-cyano-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)palmitamide |
| Synonyms | CS682; CYC682; CYC-682 |
| Molecular Formula | C26H42N4O5 |
| Molecular Weight | 490.63548 |
| Smile | CCCCCCCCCCCCCCCC(NC(C=CN1[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2C#N)=NC1=O)=O |
| InChiKey | LBGFKUUHOPIEMA-PEARBKPGSA-N |
| InChi | InChI=1S/C26H42N4O5/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-23(32)28-22-16-17-30(26(34)29-22)25-20(18-27)24(33)21(19-31)35-25/h16-17,20-21,24-25,31,33H,2-15,19H2,1H3,(H,28,29,32,34)/t20-,21+,24-,25+/m0/s1 |
| CAS Number | 151823-14-2 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Solid powder |
|---|---|
| Purity | 98% |
| Storage | -20 ºC for 3 years |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |